Bioavailability and metabolism of the flavonol quercetin in the pig

Free Radical Biology and Medicine

Volumn 28, Issue 7, 2000, Pages 1056-1067

  Ader, Peter ^a   Wessmann, Andrea ^a   Wolffram, Siegfried ^a  

^a Kiel and Lungen Clinic Grosshansdorf   (Germany)

Author keywords

Absorption; Bioavailability; Free radicals; Metabolism; Pig; Quercetin

Indexed keywords

FLAVONOID; FREE RADICAL; ISORHAMNETIN; KAEMPFEROL; PLANT EXTRACT; POLYPHENOL; QUERCETIN;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; SWINE;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; DISACCHARIDES; FLAVONOIDS; FLAVONOLS; INJECTIONS, INTRAVENOUS; KAEMPFEROLS; MALE; NEUROPROTECTIVE AGENTS; QUERCETIN; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0034108013     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00195-7     Document Type: Article

References (51)

1. Fahey G.C., Jung H.J.G. Phenolic compounds in forages and fibrous feedstuffs. Cheeke P.R. Toxicants of plant origin. 1989;123-190 CRC Press Inc, Boca Raton, Florida.
2. Kühnau J. The flavonoids. A class of semi-essential food components their role in human nutrition. Wld. Rev. Nutr. Diet. 24:1976;117-191.
3. Middleton E., Kandaswami C. The impact of plant flavonoids on mammalian biology implications for immunity, inflammation, and cancer. Harborne J.B. The flavonoids advances in research since 1986. 1994;619-652 Chapman U. Hall, London, UK.
4. Bors W., Heller W., Michel C., Stettmaier K. Flavonoids and polyphenols chemistry and biology. Cadenas E., Packer L. Handbook of antioxidants. 1996;409-468 Marcel Dekker Inc, New York.
5. Hertog, M. G. L.; Hollman, P. C. H.; van de Putte, B. Content of potentially anticarcinogenic flavonoids in tea infusions, wines, and fruit juices. J. Agric. Fd. Chem. 41:1242-1246; 1993.
6. Picinelli, A.; Suárez, B.; Mangas, J. J. Analysis of polyphenols in apple products. Z. Lebensm. Unters. Forsch. A 204:48-51; 1997.
7. Price K.R., Rhodes M.J.C. Analysis of the major flavonol glycosides present in four varieties of onion (Allium cepa) and changes in composition resulting from autolysis. J. Sci. Fd. Agric. 74:1997;331-339.
8. Linseisen J., Radtke J., Wolfram G. Flavonoidzufuhr erwachsener in einem bayerischen teilkollektiv der nationalen verzehrsstudie. Z. Ernährungswiss. 36:1997;403-412.
9. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease the Zutphen elderly study. Lancet. 342:1993;1007-1011.
10. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Fd. Chem. Toxic. 33:1995;1061-1080.
11. Packer L., Rimbach G., Virgili F. Antioxidant activity and biological properties of a procyanidin-rich extract from pine (Pinus maritima) bark pycnogenol. Free Radic. Biol. Med. 27:1999;704-724.
12. Gamet-Payrastre L., Manenti S., Gratacap M.-P., Tulliez J., Chap H., Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen. Pharmacol. 32:1999;279-286.
13. Shapiro A.B., Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem. Pharmacol. 53:1997;587-596.
14. Cermak R., Follmer U., Wolffram S. Dietary flavonol quercetin induces chloride secretion in rat colon. Am. J. Physiol. 38:1998;G1166-G1172.
15. Galvez J., Crespo M.E., Jiminez J., Suárez A., Zarzuelo A. Antidiarrheic activity of quercitrin in mice and rats. J. Pharm. Pharmacol. 45:1993;157-159.
16. Hertog M.G.L., Sweetman P.M., Fehily A.M., Elwood P.C., Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men the Caerphilly study. Am. J. Clin. Nutr. 65:1997;1489-1494.
17. Rimm E.B., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann. Intern. Med. 125:1996;384-389.
18. Hertog M.G.L., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampoli S., Jansen A., Menotti A., Nedeljkovic S., Pekkarinen M., Simic B.S., Toshima H., Feskens E.J.M., Hollman P.C.H., Katan M.B. Flavonoid intake and long term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155:1995;381-386.
19. Hertog M.G.L., Hollman P.C.H. Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr. 50:1996;63-71.
20. Hollman P.C.H., Van Trijp J.M.B., Buysman M.N.C.P., van de Gaag M.S., Mengelers M.J.B., de Vries J.H.M., Katan M.B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 418:1997;152-156.
21. Hollman P.C.H., de Vries J.H.M., Van Leeuwen S.D., Mengelers M.J.B., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62:1995;1276-1282.
22. Noteborn H.P.J.M., Jansen E., Benito S., Mengelers M.J.B. Oral absorption of quercetin and sugar-conjugated derivatives in specific transport systems. Cancer Lett. 114:1997;175-177.
23. Graefe E.U., Derendorf H., Veit M. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int. J. Clin. Pharmacol. Ther. 37:1999;219-233.
24. Stevens C.E. General characteristics of the digestive system. Stevens C.E. Comparative physiology of the vertebrate digestive system. 1988;1-21 Cambridge University Press, Cambridge.
25. Malbert C.H., Horowitz M. The pig as a model for human digestive motor activity. Laplace J.P., Fevrier C., Barbeau A. Proceedings of the VII International Symposium organized by INRA-SRP and EAAP (vol. 88). 1997;3-12 EAAP Publication.
26. Caldwell J. Glucuronic acid conjugation in the context of the metabolic conjugation of xenobiotics. Matern S., Bock K.W., Gerok W. Advances in Glucuronide Conjugation Proceedings of the 40th Falk Symposium held at Titisee, Germany, 1984. 1985;7-20 MTP Press Limited, Lancaster, England.
27. Boulton D.W., Walle U.K., Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J. Pharm. Pharmacol. 50:1998;243-249.
28. Manach C., Morand C., Texier O., Favier M.L., Agullo G., Demigné C., Régérat F., Rémésy C. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 125:1995;1911-1922.
29. Hollman P.C.H., Van Trijp J.M.B., Buysman M.N.C.P. Fluorescence detection of flavonols in HPLC by postcolumn chelation with aluminium. Anal. Chem. 68:1996;3511-3515.
30. Karnes T.H., Shiu G., Shah V.P. Validation of bioanalytical methods. Pharm. Res. 8:1991;421-434.
31. Derendorf H., Garrett E.R. Bioverfügbarkeit. Derendorf H., Garrett E.R. Pharmakokinetik einführung in die theorie und relevanz der arzneimitteltherapie. 1987;89-100 Wissenschaftliche Verlags-Gesellschaft, Stuttgart, Germany.
32. Asad S.F., Singh S., Ahmad A., Hadi S.M. Flavonoids antioxidants in diet and potential anticancer agents. Med. Sci. Res. 26:1998;723-728.
33. Meyer A.S., Heinonen M., Frankel E.N. Antioxidant interactions of catechin, cyanidin, caffeic acid, quercetin, and ellagic acid on human LDL oxidation. Fd. Chem. 61:1998;71-75.
34. Gugler R., Leschik M., Dengler H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin Pharmacol. 9:1975;229-234.
35. Manach C., Texier O., Régérat F., Agullo G., Demigné C., Rémésy C. Dietary quercetin us recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin. J. Nutr. Biochem. 7:1996;375-380.
36. Brown S., Griffith L.A. New metabolites of the naturally occuring mutagen, quercetin, the pro-mutagen rutin and of taxifolin. Experientia. 39:1982;198-200.
37. Manach C., Morand C., Demigné C., Texier O., Régérat F., Rémésy C. Bioavailability of rutin and quercetin in rats. FEBS Lett. 409:1997;12-16.
38. Piskula M.K., Yamakoshi J., Iwai Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett. 447:1999;287-291.
39. Okushio K., Suzuki M., Matsumoto N., Nanjo F., Hara Y. Methylation of tea catechins by rat liver homogenates. Biosci. Biotechnol. Biochem. 63:1999;430-432.
40. Piskula M.K., Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr. 128:1998;1172-1178.
41. Boutin J.A., Meunier F., Lambert P.-H., Hennig P., Bertin D., Serkiz B., Volland J.-P. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats. Drug Metab. Dispos. 21:1993;1157-1166.
42. Crespy V., Morand C., Manach C., Besson C., Demigne C., Remesy C. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am. J. Physiol. 277:1999;G120-G126.
43. Sfakianos J., Coward L., Kirk M., Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 127:1997;1260-1268.
44. Walle U.K., Galijatovic A., Walle T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem. Pharmacol. 58:1999;431-438.
45. Caldwell J. Comparative aspects of detoxication in mammals. Jacoby W.B. Enzymatic basis of detoxication (vol. 1). 1980;85-114 Academic Press Inc, New York.
46. Heider J., Fuchs G. Anaerobic metabolism of aromatic compounds. Eur. J. Biochem. 243:1997;577-596.
47. Tilgmann C., Ulmanen I. Purification methods of mammalian catechol-O-methyltransferases. J. Chromatogr. B. 684:1996;147-161.
48. Supko J.G., Malspeis L. Plasma pharmacokinetics of genistein in mice. Int. J. Oncol. 7:1995;847-854.
49. Hollman P.C.H., van de Gaag M., Mengelers M.J.B., Van Trijp J.M.P., De Vries J.H.M., Katan M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21:1996;703-707.
50. Ueno I., Nakano N., Hirono I. Metabolic fate of 14C quercetin in the ACI rat. Jpn. J. Exp. Med. 53:1983;41-50.
51. Manach C., Morand C., Crespy V., Demigné C., Texier O., Régérat F., Rémésy C. Quercetin is recovered in human plasma as conjugated derivatives, which retain antioxidant properties. FEBS Lett. 426:1998;331-336.